Pristimerin-induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway

Fengxia Yan1,2, Rifang Liao1,3, Marta Silva1

  • 1Faculty of Health Sciences, University of Macau, Macau, China.

Insights

Pristimerin, a natural compound, effectively inhibits uveal melanoma (UM) cell migration and invasion. It induces apoptotic cell death by targeting the PI3K/Akt/FoxO3a pathway, suggesting its potential as a UM chemotherapeutic agent.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Uveal melanoma (UM) is an aggressive eye cancer with limited treatment options for metastatic disease.
  • Pristimerin, a triterpenoid compound, exhibits anti-cancer properties but its effect on UM is largely unexplored.
  • There is a critical need for novel therapeutic strategies against metastatic UM.

Purpose of the Study:

  • To investigate the cytotoxic effects of Pristimerin on uveal melanoma cells.
  • To elucidate the underlying molecular mechanisms of Pristimerin's action in UM.
  • To evaluate Pristimerin's potential as a chemotherapeutic agent for UM.

Main Methods:

  • Treatment of UM-1 cells with Pristimerin.
  • Assessment of cell migration, invasion, reactive oxygen species (ROS) levels, and mitochondrial membrane potential.
  • Cell cycle analysis and apoptosis assays.
  • Western blot analysis to evaluate protein expression and phosphorylation.
  • Pharmacological inhibition and siRNA knockdown of key pathway proteins (PI3K, Akt, FoxO3a).

Main Results:

  • Pristimerin significantly inhibited UM-1 cell migration and invasion.
  • Pristimerin induced ROS production, decreased mitochondrial membrane potential, and caused G0/G1 cell cycle arrest, leading to apoptosis.
  • Pristimerin suppressed Akt and FoxO3a phosphorylation, promoting FoxO3a nuclear accumulation.
  • Upregulation of pro-apoptotic proteins (Bim, p27Kip1, cleaved caspase-3, PARP, Bax) and downregulation of anti-apoptotic proteins (Cyclin D1, Bcl-2) were observed.
  • Inhibition of the PI3K/Akt/FoxO3a pathway potentiated Pristimerin-induced apoptosis, while FoxO3a knockdown partially abolished its effects.

Conclusions:

  • Pristimerin induces apoptotic cell death in UM-1 cells via the PI3K/Akt/FoxO3a signaling pathway.
  • Pristimerin demonstrates significant anti-migratory and anti-invasive properties in UM cells.
  • These findings support Pristimerin as a promising candidate for the development of novel chemotherapeutic treatments for uveal melanoma.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K